Endpoints News
ASCO roundup: the new Ibrance, and why Gilead bought Tubulis Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Th Fri
22 May, 2026
LGBTQ+ LEADERSHIP IN 2026
LGBTQ+ diversity drives innovation in biopharma — but transgender and non-binary professionals face rising challenges. Endpoints is going live with our fourth annual special report celebrating the honorees giving voice and visibility while forging ahead across life sciences. Join us.
spotlight
Exclusive: Inside the covert campaign to push out FDA Commissioner Marty Makary
ENDPOINTS NEWS
news
Biogen, Denali to drop drug in non-genetic Parkinson’s after mid-stage study flop
ENDPOINTS NEWS
Ibrance's would-be successors, the data that helped sell Tubulis to Gilead and more at ASCO
ENDPOINTS NEWS
Peer Review
Amgen CFO to follow David Reese into retirement; Josh Smiley is out at Zai Lab
ENDPOINTS NEWS
Endpoints webinars
May 28
11:30 am ET
From signal to strategy: The future of systemic viral immunotherapy in GI tumors and Oncolytics Biotech
OncolyticsBiotech
Jun 11
11:00 am ET
Data-driven manufacturing: Enhancing process robustness across sites
Samsung Biologics
ENDPOINTS at #ASCO26
ASCO is about to deliver some make-or-break cancer data. Join us to figure out which pipeline bets will pay off. Get your spot now.
MORE ON #ASCO26
Merck partner Kelun outlines Phase 3 lung cancer success in China study
ENDPOINTS NEWS
At ASCO, drugmakers to offer options after Keytruda in head and neck cancer
ENDPOINTS NEWS
New data show VEGF bispecifics could compete with Summit, Akeso drug
ENDPOINTS NEWS
China’s drugmakers to take the stage at ASCO
ENDPOINTS NEWS
in case you missed it
1.
Incyte signs AI deals with Genesis and Edison, tapping its experimental data
ENDPOINTS NEWS
2.
BioMarin to seek further approval of Voxzogo in form of short stature
ENDPOINTS NEWS
3.
Lilly’s triple agonist still leads among late-stage obesity assets
ENDPOINTS NEWS
4.
Acting head of US NIH infectious disease institute has left, senators say
REUTERS
5.
FDA Plans Rare Advisory Hearing to Debate Moderna’s Flu Shot
BLOOMBERG
Elizabeth Cairns
.

Monday is Memorial Day, a public holiday in the US, and Endpoints won't be sending our usual newsletters. We'll return on Tuesday, May 26. Have a great long weekend!

.
Elizabeth Cairns
Senior Biopharma Journalist, Endpoints News
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter